Europe Artificial Organs and Bionics Market - Growth, Trends and Forecasts (2017 - 2022)

The European artificial organs & bionics market is estimated to be valued at USD 8.25 billion in the year 2014 and is expected to reach USD 14.15 billion by 2019. During this period, the market is projected to grow at a CAGR of 11.40%.

Europe Artificial Organs and Bionics Market-Market Dynamics

The report details several factors driving and restraining the market. Some of these are listed below.


It is estimated that out of the patients who need organ transplants, only 10% are provided with transplants and replacements. This has resulted in a long waiting list for the respective transplants to take place. This has been a major plus point for the artificial organs and bionics market. Some of the other factors contributing to the growth of this market are:

Rapidly aging global population

Increasing number of people suffering from organ failures

Rising incidents of motor accidents and other work-related accidents

Increasing technological advancements in the bionics sector

Scarcity of donor organs for those in need


The major restraints for the market are:

Regulatory requirements for artificial organs and bionics

Inherent expense of these products to the patients who need them

Fear of device malfunction or failure

Criticism from certain health sector personnel advising against the use of artificial organs and bionics

The European market for artificial organs and bionics is segmented on the basis of artificial organs, bionics, the technology being used and geography. The artificial organs market includes the market for vital organs such as the heart, kidney, liver, and pancreas. The bionic market includes bionic instruments for organs such as ears (cochlear), cardiac, brain and bionics for exoskeletons. The technology market is divided into electrical and mechanical.

Geographically, the market is divided into different regions namely the UK, Germany, France, Spain and the Rest of Europe. Germany is the largest market and holds about 21% of the market, followed by the UK, which holds 16% of the market. This market share can be attributed to the increasing need for transplants in this region.

Some of the key players in the market are:

Esko Bionics

F Hoffman-La Roche Ltd

Gambro AB

Iwalk Inc.

Jarvik Heart

Lifenet Health


Nano Retina, Inc.

What the Report Offers

Market definition for the European artificial organs & bionics market along with identification of key drivers and restraints for the market.

Market analysis for the European artificial organs & bionics market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their market share.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

An exhaustive understanding of the European artificial organs & bionics market.

A comprehensive analysis of the major trends, innovations and associated prospects for market growth over the coming half a decade

An ideal opportunity for industry consultants and other interested and allied parties to gain a critical insight into the factors driving and restraining the market, in addition to opportunities offered.

Wide-ranging information provided about the leading market players and the major strategies adopted by them.

1. Introduction

1.1 Report Description

1.2 Research Methodology

1.3 Major Stakeholders

2. Executive Summary

2.1 Key Findings

2.2 Market Overview

3. Market Overview

3.1 Market Definition

3.1.1 Introduction

3.2 Market Drivers

3.2.1 Scarcity of Donor Organs

3.2.2 Increased incidence of disabilities & organ failures

3.2.3 Technological Advancements

3.2.4 Rapidly aging population

3.3 Market Restraints

3.3.1 Expensive procedures

3.3.2 Fear of device malfunction and its consequences

4. Market Segmentation: Artificial Organs

4.1 Artificial Heart

4.1.1 Prosthetic Heart Valves

4.1.2 Ventricular Assist Devices

4.2 Artificial Kidney

4.2.1 Dialysis

4.3 Artificial Livers

4.3.1 Liver Dialysis

4.3.2 Bioartificial Liver Device (BAL)

4.3.3 Molecular Adsorbent Recirculation Systems (MARS)

4.3.4 Single Pass Albumin Dialysis (SPAD)

4.3.5 Prometheus

4.4 Artificial Pancreas

4.4.1 Insulin Pump

4.5 Artificial Lungs

4.5.1 Extracorporeal membrane oxygenation

4.5.2 Heart-Lung Machines

5. Market Segmentation: Bionic Implants/Devices

5.1 Cochlear bionics

5.2 Vision Bionics

5.3 Orthopedic Bionics

5.3.1 Bionic Limbs

5.3.2 Bionic Legs

5.3.3 Bionic Limbs

5.4 Cardiac Bionics

5.4.1 Heart Valves

5.5 Brain Bionics

5.5.1 Brain

5.5.2 Spinal Cord

5.5.3 Nerve Stimulation

5.6 Exoskeletons

6. Market Segmentation: Technology

6.1 Electrical

6.2 Mechanical

7. Market Segmentation: Geography

7.1 Europe

7.1.1 UK

7.1.2 Germany

7.1.3 France

7.1.4 Spain

7.1.5 Italy

7.1.6 Others

8. Competitive Landscape

8.1 Mergers & Acquisitions

8.2 New Product Launches

8.3 Agreements, Collaborations & Partnerships

8.4 Market Chain Analysis

8.5 Price Share Analysis

9. Company Profiles

9.1 Abiomed Inc.

9.2 Asahi Kasei Medical Co., Ltd

9.3 Baxter International, Inc.

9.4 Berlin Heart GmbH

9.5 Boston Scientific Corporation

9.6 Cochlear Limited

9.7 Cyberonics

9.8 Edward Lifesciences Corporation

9.9 Esko Bionics

9.10 F Hoffman-La Roche Ltd

9.11 Gambro AB

9.12 Iwalk Inc.

9.13 Jarvik Heart

9.14 Medtronic

9.15 Lifenet Health

9.16 Nano Retina,Inc.

9.17 Ossur

9.18 Otto Bock Healthcare GmbH

9.19 Second Sight Medical Products

9.20 Thoratec Corporation

9.21 Touch Bionics

9.22 Worldheart Corporation

10. Appendix

10.1 Abbreviations

10.2 Sources

10.3 Bibliography

10.4 Disclaimer

Content are not available

Choose License Type